fbpx

Research

310 results.

August 28, 2023 Preliminary phase 2 trial results of lixisenatide presented

Copenhagen, Denmark (August 28, 2023) — A one-year, phase 2 clinical trial of Type 2 diabetes drug lixisenatide has reported positive early results, which indicate…

August 24, 2023 Repairing broken brain circuits may offer path to new Parkinson’s treatments

GRAND RAPIDS, Mich. (August 24, 2023) — Van Andel Institute scientists have identified a series of processes that help the brain adapt to damage…

August 17, 2023 A decade of ‘green’ leadership

Sustainability has been foundational to Van Andel Institute since day one.

Our commitment to green practices can be seen throughout our facilities, from extensive recycling…

August 8, 2023 Generosity of VAI employees empowers osteoporosis discovery

What started as a question about an odd bone could one day lead to new ways to treat osteoporosis with fewer side effects, thanks to…

August 1, 2023 Van Andel Institute appoints neurobiologist Dr. Laurent Roybon as associate professor

GRAND RAPIDS, Mich. (August 1, 2023) — Van Andel Institute has appointed Laurent Roybon, Ph.D., as an associate professor in its Department…

July 28, 2023 Alternative cellular ‘fuels’ boost immunity

GRAND RAPIDS, Mich. (July 28, 2023) — A metabolic by-product that is more prevalent during fasting may supercharge immune cells as they fight infection and…

June 30, 2023 Meet the graduate student: Elshaimaa Ali

Throughout the year, we highlight Van Andel Institute Graduate School’s doctoral students. This month, we’re featuring Elshaimaa Ali, a Ph.D. candidate in the…

June 22, 2023 Breakdown of ‘protective mechanisms’ can drive lung cancer development

GRAND RAPIDS, Mich. (June 22, 2023) — Loss of two key “protector” proteins initiates epigenetic changes that transform healthy lung cells into cancerous ones, according…